PFG Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
PFG Advisors's BMY Position: Q3 2026 in Review
PFG Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,235 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #740 among its holdings. This is a return to the name: PFG Advisors previously reported a position in BMY as recently as Q1 2026.
PFG Advisors first reported a position in BMY in Q1 2020 and has held it in 24 quarters since. The position peaked at $674K in Q4 2022. 979 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- PFG Advisors held 3,235 shares of Bristol-Myers Squibb worth $202K as of Q3 2026.
- Bristol-Myers Squibb was a new PFG Advisors position in Q3 2026.
- Bristol-Myers Squibb made up 0.01% of PFG Advisors's portfolio in Q3 2026, its #740 holding.
- PFG Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 24 quarters since.
- PFG Advisors's Bristol-Myers Squibb position peaked at $674K in Q4 2022.
- 979 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.